RARECast
Un podcast de RARECast - Les jeudis
548 Épisodes
-
A Heart Attack that Led to a Rare Disease Diagnosis
Publié: 30/01/2025 -
Targeting Rare Liver Diseases with Gene Editing Therapies
Publié: 23/01/2025 -
Using AI to De-Risk Rare Disease Drug Development
Publié: 16/01/2025 -
Addressing a Growing Demand for Plasma-Derived Therapies
Publié: 09/01/2025 -
Empowering Patients with Data to Drive Drug Development
Publié: 02/01/2025 -
How Advocates Are Advancing a Treatment for an Ultra-Rare Disease
Publié: 26/12/2024 -
Engineering B Cells to Produce Therapeutic Proteins
Publié: 19/12/2024 -
A Pipeline Win as BridgeBio Learns to Balance Theory with Practice
Publié: 12/12/2024 -
Considering What It Will Take for Payers to Embrace Advances in Sequencing
Publié: 05/12/2024 -
Finding Strength
Publié: 27/11/2024 -
A Non-Profit Works to Advance a DMD Gene Therapy
Publié: 21/11/2024 -
Accepting What We Can’t Understand
Publié: 14/11/2024 -
A Gene Therapy Company Born from a Father’s Efforts to Save his Daughter
Publié: 07/11/2024 -
Lowering Barriers to Clinical Trial Participation with Do-It-Yourself Blood Sample Collection
Publié: 31/10/2024 -
Scaling N-of-1 Therapies to Viability
Publié: 24/10/2024 -
Building Gene Therapies that Address Gain and Loss of Function Simultaneously
Publié: 17/10/2024 -
How One Woman Climbed from Patient to Advocate
Publié: 10/10/2024 -
Shortening the Diagnostic Odyssey
Publié: 03/10/2024 -
Making Exomes More Revealing
Publié: 26/09/2024 -
How One Patient Organization Catalyzed Drug Development
Publié: 19/09/2024
RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.
